Infertile men have higher levels of semen reactive oxygen species (ROS) than do fertile men. High levels of semen ROS can cause sperm dysfunction, sperm DNA damage and reduced male reproductive potential. This observation has led clinicians to treat infertile men with antioxidant supplements. The purpose of this article is to discuss the rationale for antioxidant therapy in infertile men and to evaluate the data on the efficacy of dietary and in vitro antioxidant preparations on sperm function and DNA damage. To date, most clinical studies suggest that dietary antioxidant supplements are beneficial in terms of improving sperm function and DNA integrity. However, the exact mechanism of action of dietary antioxidants and the optimal dietary supplement have not been established. Moreover, most of the clinical studies are small and few have evaluated pregnancy rates. A beneficial effect of in vitro antioxidant supplements in protecting spermatozoa from exogenous oxidants has been demonstrated in most studies; however, the effect of these antioxidants in protecting sperm from endogenous ROS, gentle sperm processing and cryopreservation has not been established conclusively. Keywords: antioxidant; male infertility; oxidative stress; sperm DNA fragmentation; vitamins RELATIONSHIP BETWEEN OXIDATIVE STRESS AND SPERM DYSFUNCTION Seminal oxidative stress (OS) results from an imbalance between reactive oxygen species (ROS) production and ROS scavenging by seminal antioxidants. Seminal OS is believed to be one of the main factors in the pathogenesis of sperm dysfunction and sperm DNA damage in male infertility.
RELATIONSHIP BETWEEN OXIDATIVE STRESS AND SPERM DYSFUNCTION
Seminal oxidative stress (OS) results from an imbalance between reactive oxygen species (ROS) production and ROS scavenging by seminal antioxidants. Seminal OS is believed to be one of the main factors in the pathogenesis of sperm dysfunction and sperm DNA damage in male infertility. [1] [2] [3] [4] Indeed, it is estimated that 25% of infertile men possess high levels of semen ROS, whereas fertile men do not have high levels of semen ROS.
1,4-6 Although a controlled production of these ROS is required for sperm physiology (sperm hyperactivation, capacitation and acrosome reaction) and for natural fertilization, [7] [8] [9] the excessive production of ROS by immature germ cells and leukocytes causes sperm dysfunction (lipid peroxidation, loss of motility and sperm DNA damage). 9, 10 Spermatozoa are particularly susceptible to oxidative injury due to the abundance of plasma membrane polyunsaturated fatty acids. [10] [11] [12] These unsaturated fatty acids provide fluidity that is necessary for membrane fusion events (e.g., the acrosome reaction and sperm-egg interaction) and for sperm motility. However, the unsaturated nature of these molecules predisposes them to free radical attack and ongoing lipid peroxidation throughout the sperm plasma membrane. Once this process has been initiated, accumulation of lipid peroxides occurs on the sperm surface (this results in loss of sperm motility) and oxidative damage to DNA can ensue. 13, 14 SEMINAL ANTIOXIDANT CAPACITY AND SPERM DYSFUNCTION Seminal plasma and spermatozoa themselves are well endowed with an array of protective antioxidants to protect spermatozoa from OS, especially, at the post-testicular level. 6, 15, 16 Seminal plasma contains a number of high-molecular weight enzymatic antioxidants (superoxide dismutase, catalase and glutathione peroxidase) and a deficiency in these enzymes has been reported to cause sperm DNA damage and male infertility. 1,7,10, [17] [18] [19] Seminal fluid also contains non-enzymatic antioxidants (ascorbic acid, a-tocopherol, pyruvate, glutathione, Lcarnitine, taurine and hypotaurine) [20] [21] [22] [23] which constitute the bulk of seminal antioxidant capacity. In addition, urate, 24 pyruvate, 11, 25 albumin, beta carotenes and ubiquinol 26 have been detected in seminal plasma.
A number of investigators have shown that seminal antioxidant capacity is suppressed in infertile men with high ROS levels compared to men with normal levels of ROS. 20, 27, 28 However, it is unclear whether reduced semen antioxidant capacity necessarily causes sperm dysfunction (including sperm DNA damage). 1, 3, 29, 30 Indeed, there is some controversy as to whether the high ROS levels detected in the semen of infertile men are due to increased ROS production, decreased ROS scavenging capacity or both. 21, 31 If the high semen ROS levels are due (at least in part) to a decreased ROS scavenging capacity of semen, it would support the use of dietary antioxidant supplementation. 21, 31 TREATMENT OF OXIDATIVE STRESS Treatment of oxidative stress should first involve strategies to reduce or eliminate stress-provoking conditions including smoking, varicocele, genital infection, gonadotoxins and hyperthermia. The rationale for treating infertile men with oral antoxidants is based on the premise that seminal oxidative stress (common in infertile men) is due in part to a deficiency in seminal antioxidants. The practice of prescribing oral antioxidant is supported by the lack of serious side effects related to antioxidant therapy, although few studies have carefully evaluated the risk of overtreatment with antioxidants. 36 Ideally, an oral antioxidant should reach high concentrations in the reproductive tract and replete a deficiency of vital elements important for spermatogenesis. Additionally, the antioxidant supplement should augment the scavenging capacity of seminal plasma and reduce the levels of semen ROS.
1 However, the levels of semen ROS should not be entirely suppressed (by oral antioxidants) as this may impair normal sperm functions (e.g., sperm capacitation and hyperactivation) that normally require low levels of ROS. 7, 9, 19 To date, over 100 clinical and experimental studies have examined the effect of antioxidants on sperm parameters. Despite this large body of literature, it is not possible to establish firm conclusions regarding the optimal antioxidant treatment for infertile men because the published studies report on different types and doses of antioxidants, the studies are small, the end points vary and few of the studies are placebo-controlled. 1, 6, 15 Moreover, the presumed mechanism of action of antioxidants in the treatment of male infertility (i.e., suppression of seminal OS) has not been confirmed because few studies have evaluated seminal OS and/or antioxidant capacity before and after treatment. 37, 38 Effect of oral (dietary) antioxidants on sperm dysfunction and DNA damage While there is a good body of literature on the effect of oral antioxidants on sperm parameters (including sperm DNA integrity), no study has established the optimal dose, duration of treatment or subpopulation of infertile patients who might benefit most from antioxidant therapy (isolated asthenozoospermia, oligoasthenoteratozoospermia, sperm DNA damage or all). Many small, uncontrolled studies have shown a significant improvement in semen parameters following different doses and types of antioxidant therapy.
6, 15 The most commonly studied oral antioxidants (or antioxidant enzyme cofactors) include vitamin C, vitamin E, selenium, zinc, glutathione, L-carnitine and N-acetyl cysteine.
The randomized controlled trials (RCTs) on antioxidant therapy for male infertility generally demonstrate that treatment with antioxidants has a beneficial effect (in terms of semen parameter improvements), whereas no significant effect is seen in the placebo group 37, (Tables 1 and 2 ). The variable treatment outcomes in different studies could be due to differences in vitamin dosages, duration of treatment and patient population. 6, 15 One RCT evaluated the effects of vitamin C alone and reported a significant improvement in sperm parameters in the treatment arm only. 46 Six RCTs evaluated the effects of vitamin E alone or in combination with vitamin C or selenium. Two of these studies reported a significant improvement in sperm motility 39, 41 and one reported a significant improvement in sperm DNA integrity 59 in the treatment arm only. In contrast, three RCTs reported no significant improvement in sperm parameters after vitamin E6C treatment, [56] [57] [58] although sperm-zona binding improved in one of these studies. 56 Five RCTs evaluated the effects of zinc alone or in combination with folic acid and all five reported a significant improvement in sperm parameters in the treatment arm only. 47, [50] [51] [52] [53] [54] [55] Three RCTs evaluated the effects of selenium alone or in combination with N-acetyl cysteine and two of the three studies reported a significant improvement in sperm parameters in the treatment arm only. 43, 48, 54 Four RCTs evaluated the effects of L-carnitine alone or in combination with L-acetyl carnitine and three of the four reported a significant improvement in sperm parameters in the treatment arm only. 42, 44, 49, 60 Three RCTs evaluated the effects of N-acetyl cysteine alone or in combination with selenium and all three reported a significant improvement in sperm parameters in the treatment arm only. 45, 54, 61 Several investigators have examined the effect of antioxidant therapy on sperm DNA integrity because sperm DNA damage may be caused, at least in part, by oxidative stress. 15, 22, 29, 53, [62] [63] [64] [65] [66] [67] [68] [69] In addition, sperm DNA damage is a more reliable outcome measure than sperm concentration or motility because measures of sperm DNA damage exhibit a lower degree of biological variability than conventional semen parameters. [70] [71] [72] Treatment with oral antioxidants has generally been associated with improvement in sperm DNA integrity and in some cases pregnancy rates after assisted reproduction, although most of these studies are small and few are randomized placebo-controlled trials ( Table 3) .
1 To date, none of the studies on sperm DNA damage and oral antioxidants have estimated seminal oxidative stress, seminal vitamin levels or used oxidative DNA damage (e.g., by estimation of 8-hydroxy-29-deoxyguanosine (8-OHdG)) as a selection criterion for monitoring the response to antioxidant treatment. 1,2,73 As such, the precise mechanism of action of these antioxidant supplements on sperm DNA quality is unknown.
Effect of in vitro antioxidants on sperm dysfunction and DNA damage The generation of oxidative stress in the in vitro environment, either by direct application of ROS (exogenous) or activation of intrinsic sperm ROS (endogenous), has been associated with clinical evidence of lipid peroxidation, sperm dysfunction and sperm DNA damage. 13, 14, [74] [75] [76] [77] [78] This is particularly important in the context of in vitro fertilization where seminal plasma is removed during semen processing and the toxic oxygen metabolites (generated by immature spermatozoa and leukocytes) are able to attack spermatozoa without being protected by seminal plasma antioxidants. In addition, the detrimental effect of oxidative stress on sperm functional competence can be exaggerated by the in vitro sperm processing techniques (centrifugation and prolonged incubation) that usually precede assisted reproductive techniques.
1,14,75,79

ROLE OF IN VITRO ANTIOXIDANTS IN PROTECTING SPERMATOZOA FROM EXOGENOUS ROS
Attenuating the effects of exogenous ROS is clinically relevant as many of the semen samples from infertile men contain abnormal spermatozoa and leukocytes, and, these cells have the potential to generate exogenous ROS. 76 Antioxidants such as vitamin E, catalase and glutathione have been shown to protect sperm motility from the effects of exogenous ROS (Table 4) . 11, 80 In contrast, superoxide dismutase is less effective in preventing the loss of motility due to exogenous oxidants. 11, 80 Altogether, these data suggest that hydrogen peroxide (H 2 O 2 ) is the most sperm-toxic ROS. Antioxidants have also been shown to protect the sperm DNA from the effects of exogenous ROS (Table 4) . [81] [82] [83] [84] This is highly relevant as sperm DNA damage may impact on reproductive outcomes after assisted reproductive technologies. 6 Indeed, sperm DNA damage has been associated with reduced pregnancy rates with intrauterine insemination, and, to a lesser extent with conventional in vitro fertilization.
5,85,86
ROLE OF IN VITRO ANTIOXIDANTS IN PROTECTING SPERMATOZOA FROM ENDOGENOUS ROS
Spermatozoa can be stimulated to generate ROS using a variety of agents (e.g., NADPH and estrogens) and this ROS production can potentially impair sperm function. 87 In contrast to the beneficial effect of antioxidants in protecting spermatozoa from exogenous ROS, antioxidants appear to be of limited value in protecting spermatozoa from endogenous ROS production. 14 Twigg et al. demonstrated that SOD, catalase or both are ineffective, whereas albumin is effective in protecting spermatozoa from loss of motility due to endogenous ROS generation.
14 These studies stress the importance of using gentle semen processing protocols (e.g., low centrifugation force) so as to minimize the production and adverse impact of endogenous ROS.
Similarly, antioxidants appear to be of limited value in protecting the DNA of normal spermatozoa (with normal chromatin compaction) 
Concentration
Abbreviations: LC, L-carnitine; LAC, L-acetyl carnitine; MDA, malondialdehyde; NAC, N-acetyl cysteine; OAT, oligoasthenoteratospermia; RCT, randomized controlled trial.
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A Zini and N Al-Hathal 377 from endogenous ROS production (e.g., NADPH-induced or centrifugation-induced). 14, 77, 88, 89 In samples with poor morphology and poor sperm chromatin compaction, antioxidants may protect the sperm DNA from endogenous ROS production, as these samples are more vulnerable to oxidative stress. 90, 91 In support of these clinical observations, experimental (animal) studies suggest that the spermatozoa of infertile men may be more susceptible to oxidative injury in vitro but benefit more so from antioxidants than the spermatozoa of fertile men. 92 
ROLE OF IN VITRO ANTIOXIDANTS IN PROTECTING SPERMATOZOA FROM SEMEN PROCESSING
Several studies have reported on the effects of antioxidants in preventing the decline in sperm motility after semen processing and incubation (Table 5 ). These studies have clinical relevance because it is important to maximize sperm motility prior to assisted reproductive techniques such as intrauterine insemination and standard in vitro fertilization. The available studies report conflicting results regarding the effects of antioxidants in preventing the loss of sperm motility during sperm processing such as centrifugation and incubation. Some studies have shown that antioxidants (e.g., vitamin E, glutathione, N-acetyl cysteine, catalase and ferulic acid) are effective in reducing ROS levels and in preventing the decline in sperm motility during sperm processing. [93] [94] [95] [96] In contrast, other studies have reported that antioxidants (e.g., glutathione and catalase) are ineffective in protecting spermatozoa from the loss of motility during sperm processing. [97] [98] [99] It is important to note that sperm samples from infertile men may be more susceptible to oxidative injury (from semen processing) and be afforded greater protection by antioxidants than samples from fertile men. 92 Antioxidants appear to be of limited value in protecting sperm DNA from gentle semen processing (e.g., incubation or densitygradient centrifugation) ( Table 5) . [98] [99] [100] [101] In some cases, antioxidants supplementation in vitro (e.g., combination of vitamins C and E) may cause sperm DNA damage. 99, 101 ROLE OF IN VITRO ANTIOXIDANTS IN PROTECTING SPERMATOZOA FROM CRYOPRESERVATION AND THAWING Several studies have evaluated the role of antioxidants in protecting spermatozoa from the loss of motility that occurs following cryopreservation and thawing. Most studies have reported on the use of pentoxifilline (an antioxidant and phosphodiesterase inhibitor). Some studies have shown that pentoxifilline improves post-thaw sperm motility and/or sperm function, [102] [103] [104] [105] whereas others have demonstrated that this antioxidant does not have a beneficial effect. 106 Other antioxidants (vitamins E and C and rebamipide) have been used to enhance post-thaw motility; however, the results have been modest. 107, 108 Several studies have also examined the role of antioxidants in protecting sperm DNA from injury following cryopreservation and thawing. Most studies have shown that antioxidants (vitamin C, catalase, resveratrol and genistein) can protect the sperm DNA from oxidative injury during cryopreservation and subsequent thawing [109] [110] [111] [112] ( Table 6 ). In contrast, Taylor et al. reported that the antioxidant vitamin E does not protect sperm DNA during cryopreservation. 113 Taken together, the data suggest that antioxidants are generally effective in protecting spermatozoa from the effects of cryopreservation and thawing. However, the technique of cryopreservation and 101 
COMET
Percoll DGC Vitamins C, E or urate lower sperm DD after DGC Vitamins C1E or AC increase sperm DD after DGC Abbreviations: AC, acetyl cysteine; CF, centrifugation; COMET, alkaline single-cell gel electrophoresis; DD, DNA damage; DGC, density-gradient centrifugation; DTT, dithiotreitol; GSH, glutathione; LPO, lipid peroxidation; NAC, N-acetyl-L-cysteine; ROS, reactive oxygen species; SOD, superoxide dismutase.
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SUMMARY
Oxidative stress plays an important role in the pathophysiology of male infertility. The published studies on dietary antioxidants (including randomized, placebo-controlled trials) generally demonstrate a beneficial effect of antioxidants on sperm function. However, the mechanism of action of these antioxidants as well as the optimal type and dosage of antioxidant is unknown. The study of in vitro antioxidants is highly relevant in the era of assisted reproduction because of the susceptibility of human spermatozoa to oxidative injury and the vulnerability of these cells during semen processing. Most studies have demonstrated a beneficial effect of in vitro antioxidant supplements in protecting spermatozoa from exogenous oxidants and cryopreservation (with subsequent thawing). In contrast, the effect of these antioxidants in protecting normal spermatozoa from endogenous ROS and gentle sperm processing has not been established conclusively. Additional studies are needed to determine the optimal antioxidant preparation to protect spermatozoa from oxidative stress in vitro. Antioxidant therapy in male infertility A Zini and N Al-Hathal 379
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